Lorne Steinberg Wealth Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$388K Hold
3,023
0.08% 61
2026
Q1
$364K Hold
3,023
0.09% 60
2025
Q4
$318K Hold
3,023
0.07% 61
2025
Q3
$254K Buy
3,023
+400
+15% +$32.9K 0.06% 65
2025
Q2
$208K Hold
2,623
0.05% 70
2025
Q1
$235K Hold
2,623
0.07% 65
2024
Q4
$261K Hold
2,623
0.08% 63
2024
Q3
$298K Hold
2,623
0.09% 63
2024
Q2
$325K Hold
2,623
0.1% 62
2024
Q1
$346K Hold
2,623
0.11% 64
2023
Q4
$286K Sell
2,623
-400
-13% -$41.5K 0.1% 65
2023
Q3
$311K Hold
3,023
0.12% 63
2023
Q2
$349K Sell
3,023
-200
-6% -$22.7K 0.13% 60
2023
Q1
$343K Hold
3,223
0.14% 60
2022
Q4
$358K Hold
3,223
0.15% 62
2022
Q3
$278K Hold
3,223
0.14% 58
2022
Q2
$294K Hold
3,223
0.14% 60
2022
Q1
$264K Hold
3,223
0.12% 58
2021
Q4
$247K Hold
3,223
0.11% 61
2021
Q3
$242K Hold
3,223
0.12% 61
2021
Q2
$251K Sell
3,223
-155
-5% -$11.5K 0.12% 59
2021
Q1
$248K Hold
3,378
0.13% 58
2020
Q4
$2.65M Buy
+3,378
New +$258K 1.65% 29

Other funds holding MRK

Lorne Steinberg Wealth Management's MRK Position: Q2 2026 in Review

Lorne Steinberg Wealth Management held its Merck (MRK) position steady in Q2 2026 at 3,023 shares worth $388K. The position accounts for 0.08% of the portfolio, ranked #61.

Lorne Steinberg Wealth Management first reported a position in MRK in Q4 2020 and has held it in 23 quarters since. The position peaked at $2.65M in Q4 2020. 1,784 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Lorne Steinberg Wealth Management held 3,023 shares of Merck worth $388K as of Q2 2026.
  • Lorne Steinberg Wealth Management left its Merck share count unchanged in Q2 2026.
  • Merck made up 0.08% of Lorne Steinberg Wealth Management's portfolio in Q2 2026, its #61 holding.
  • Lorne Steinberg Wealth Management first reported a position in Merck in Q4 2020 and has held it in 23 quarters since.
  • Lorne Steinberg Wealth Management's Merck position peaked at $2.65M in Q4 2020.
  • 1,784 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Lorne Steinberg Wealth Management's 13F filing for Q2 2026, filed 28 Jul 2026.